Discharge Planning in Emergency Department for Frail Older With AHF
NCT ID: NCT03696875
Last Updated: 2019-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1260 participants
INTERVENTIONAL
2019-05-20
2022-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method: Investigators will select frail patients ≥70 years with primary diagnosis of AHF discharged from EDs. The intervention will consist of MGDP implementation: 1) checklist that includes clinical recommendations and resources activations; 2) scheduling of early visit with the specialist; 3) communication with primary care; 4) providing a written instruction sheet to patient or caregiver. Phase 1: matched-pair cluster randomized clinical trial. EDs were randomly allocated to intervention (n = 10) or control (n = 10) group. Investigators will compare the outcomes between intervention and control groups. Phase 2: a quasi-experimental study. The 20 EDs will carry out the intervention. Investigators will compare the outcomes between phase 1 and phase 2 of intervention group and between phase 1 and phase 2 of control group. The main outcome is a 30-day composite endpoint (ED revisit or hospital admission for AHF and cardiovascular death) after being discharged.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient-centered Care Transitions in Heart Failure: A Pragmatic Cluster Randomized Trial
NCT02112227
DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics
NCT04877652
Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure
NCT03246035
Early Care After Discharge of HF Patients
NCT01820780
Improving Risk Stratification of Emergency Department Patients With Acute Heart Failure
NCT06065761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multilevel Guided Discharge Planning
Multilevel Guided Discharge Planning
Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient
Standard of care
Standard of care
Standard of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multilevel Guided Discharge Planning
Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient
Standard of care
Standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of descompensated chronic heart failure.
* Screening for frailty positive (ISAR ≥ 2).
* Planned discharge home from Emergency Department (included observation and short stay unit).
* Written informed consent provided by the patient or proxy.
Exclusion Criteria
* Severe episode of acute heart failure (≥9th decile of MEESSI-AHF Score).
* Uncorrected clinically significant primary valvular disease.
* Acute coronary syndrome currently or within 30 days prior to enrolment.
* Surgery or implanted device within 30 days prior to enrolment.
* Significant arrhythmias.
* Uncorrected systolic blood pressure \< 100 mmHg, O2 saturation baseline \< 92%, heart rate \< 60 or \>110 bpm, serum sodium \< 130 mmol/l, serum potassium \>5,5 mmol/l or hemoglobin \<9 g/dL prior to enrolment.
* Planned treatment with vasoactive therapies, ventricular assist device, heart surgery or transplant within 6 months.
* End stage renal disease.
* Severe disability.
* Difficulty intervention due to significant dementia, active delirium or psychiatric disorder.
* Condition with a life expectancy \<1 year.
* Length of stay in Emergency Department ≥96 hours.
* Discharged to facility care.
* Inability of outpatient follow-up.
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
F. Javier Martin Sanchez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
F. Javier Martin Sanchez
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinico San Carlos
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEED FRAIL-AHF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.